2-181604076-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_201548.5(CERKL):​c.242A>C​(p.Asp81Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 1,591,672 control chromosomes in the GnomAD database, including 16,562 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D81V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.14 ( 1636 hom., cov: 32)
Exomes 𝑓: 0.14 ( 14926 hom. )

Consequence

CERKL
NM_201548.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.95

Publications

19 publications found
Variant links:
Genes affected
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]
CERKL Gene-Disease associations (from GenCC):
  • CERKL-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 26
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025988221).
BP6
Variant 2-181604076-T-G is Benign according to our data. Variant chr2-181604076-T-G is described in ClinVar as Benign. ClinVar VariationId is 257150.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CERKLNM_201548.5 linkc.242A>C p.Asp81Ala missense_variant Exon 2 of 13 ENST00000410087.8 NP_963842.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CERKLENST00000410087.8 linkc.242A>C p.Asp81Ala missense_variant Exon 2 of 13 1 NM_201548.5 ENSP00000386725.3

Frequencies

GnomAD3 genomes
AF:
0.137
AC:
20814
AN:
151868
Hom.:
1630
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.0778
Gnomad EAS
AF:
0.258
Gnomad SAS
AF:
0.0624
Gnomad FIN
AF:
0.217
Gnomad MID
AF:
0.0385
Gnomad NFE
AF:
0.136
Gnomad OTH
AF:
0.117
GnomAD2 exomes
AF:
0.148
AC:
36349
AN:
245128
AF XY:
0.140
show subpopulations
Gnomad AFR exome
AF:
0.106
Gnomad AMR exome
AF:
0.218
Gnomad ASJ exome
AF:
0.0708
Gnomad EAS exome
AF:
0.250
Gnomad FIN exome
AF:
0.228
Gnomad NFE exome
AF:
0.133
Gnomad OTH exome
AF:
0.141
GnomAD4 exome
AF:
0.137
AC:
197234
AN:
1439686
Hom.:
14926
Cov.:
29
AF XY:
0.134
AC XY:
95816
AN XY:
717346
show subpopulations
African (AFR)
AF:
0.0959
AC:
3096
AN:
32282
American (AMR)
AF:
0.212
AC:
9408
AN:
44318
Ashkenazi Jewish (ASJ)
AF:
0.0715
AC:
1853
AN:
25924
East Asian (EAS)
AF:
0.239
AC:
9403
AN:
39326
South Asian (SAS)
AF:
0.0570
AC:
4883
AN:
85704
European-Finnish (FIN)
AF:
0.230
AC:
12161
AN:
52794
Middle Eastern (MID)
AF:
0.0473
AC:
268
AN:
5660
European-Non Finnish (NFE)
AF:
0.135
AC:
148169
AN:
1094096
Other (OTH)
AF:
0.134
AC:
7993
AN:
59582
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
7083
14166
21250
28333
35416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5372
10744
16116
21488
26860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.137
AC:
20840
AN:
151986
Hom.:
1636
Cov.:
32
AF XY:
0.142
AC XY:
10572
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.107
AC:
4453
AN:
41472
American (AMR)
AF:
0.176
AC:
2690
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0778
AC:
270
AN:
3472
East Asian (EAS)
AF:
0.257
AC:
1329
AN:
5174
South Asian (SAS)
AF:
0.0628
AC:
303
AN:
4822
European-Finnish (FIN)
AF:
0.217
AC:
2290
AN:
10536
Middle Eastern (MID)
AF:
0.0379
AC:
11
AN:
290
European-Non Finnish (NFE)
AF:
0.136
AC:
9215
AN:
67942
Other (OTH)
AF:
0.120
AC:
253
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
898
1796
2694
3592
4490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.129
Hom.:
2344
Bravo
AF:
0.134
TwinsUK
AF:
0.141
AC:
521
ALSPAC
AF:
0.136
AC:
523
ESP6500AA
AF:
0.112
AC:
492
ESP6500EA
AF:
0.128
AC:
1097
ExAC
AF:
0.140
AC:
16937

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa 26 Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Retinitis pigmentosa Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.043
.;.;.;T;.
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.71
T;T;T;T;T
MetaRNN
Benign
0.0026
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;L;L;L;L
PhyloP100
2.0
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.8
D;D;N;D;D
REVEL
Benign
0.12
Sift
Benign
0.16
T;T;D;T;T
Sift4G
Uncertain
0.019
D;D;D;D;D
Polyphen
0.78
P;.;P;P;P
Vest4
0.40
MPC
0.18
ClinPred
0.014
T
GERP RS
3.0
Varity_R
0.084
gMVP
0.38
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61750041; hg19: chr2-182468803; COSMIC: COSV59212557; API